TScan Therapeutics, Inc. (TCRX)
0.2377
+0.03
(+12.87%)
USD |
NASDAQ |
Oct 15, 16:00
0.2377
0.00 (0.00%)
After-Hours: 20:00
TScan Therapeutics Market Cap : 16.11M for Oct. 15, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 14, 2026 | 14.27M |
| October 13, 2026 | 14.69M |
| October 12, 2026 | 16.12M |
| October 09, 2026 | 16.13M |
| October 08, 2026 | 15.47M |
| October 07, 2026 | 18.77M |
| October 06, 2026 | 18.67M |
| October 05, 2026 | 20.02M |
| October 02, 2026 | 21.72M |
| October 01, 2026 | 21.52M |
| September 30, 2026 | 21.32M |
| September 29, 2026 | 21.52M |
| September 28, 2026 | 23.04M |
| September 25, 2026 | 23.04M |
| September 24, 2026 | 23.66M |
| September 23, 2026 | 24.67M |
| September 22, 2026 | 24.05M |
| September 21, 2026 | 22.41M |
| September 18, 2026 | 21.14M |
| September 17, 2026 | 22.60M |
| September 16, 2026 | 22.43M |
| September 15, 2026 | 21.78M |
| September 14, 2026 | 20.76M |
| September 11, 2026 | 21.72M |
| September 10, 2026 | 21.55M |
| Date | Value |
|---|---|
| September 09, 2026 | 22.37M |
| September 08, 2026 | 23.37M |
| September 04, 2026 | 26.54M |
| September 03, 2026 | 25.14M |
| September 02, 2026 | 25.83M |
| September 01, 2026 | 45.16M |
| August 31, 2026 | 49.46M |
| August 28, 2026 | 51.07M |
| August 27, 2026 | 50.85M |
| August 26, 2026 | 52.69M |
| August 25, 2026 | 53.80M |
| August 24, 2026 | 54.18M |
| August 21, 2026 | 52.83M |
| August 20, 2026 | 52.61M |
| August 19, 2026 | 50.83M |
| August 18, 2026 | 55.90M |
| August 17, 2026 | 53.11M |
| August 14, 2026 | 52.79M |
| August 13, 2026 | 52.33M |
| August 12, 2026 | 52.39M |
| August 11, 2026 | 52.65M |
| August 10, 2026 | 51.99M |
| August 07, 2026 | 53.97M |
| August 06, 2026 | 45.87M |
| August 05, 2026 | 46.88M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 285.10M |
| Amgen, Inc. | 234.63B |
| Anika Therapeutics, Inc. | 277.16M |
| BioCryst Pharmaceuticals, Inc. | 2.046B |
| Imunon, Inc. | 4.899M |
Market Cap Related Metrics
| PS Ratio | 4.342 |
| Price to Book Value | 0.2334 |
| Price | 0.2377 |
| Earnings Yield | -381.2% |